Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers

被引：0
|
作者：
Agarwal, Indu [1 ]
Sullivan, Megan E. [1 ]
机构：
[1] NorthShore Univ Hlth Syst, Evanston, IL USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
124
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [32] Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing
    Sim, Wey Cheng
    Lee, Chee Yang
    Richards, Rebecca
    Bettens, Karolien
    Mottier, Violaine
    Goh, Liuh Ling
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 116
  • [33] Breast Cancer Risk Associated With CHEK2 Mutations
    Mahon, Suzanne M.
    ONCOLOGY NURSING FORUM, 2014, 41 (06) : 692 - 694
  • [34] Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations
    Hoste, G.
    D'Hoore, P.
    Legius, E.
    Van Buggenhout, G.
    Floris, G.
    Wildiers, H.
    Han, S. N.
    Van Nieuwenhuysen, E.
    Berteloot, P.
    Smeets, A.
    Nevelsteen, I.
    Weltens, C.
    Janssen, H.
    Van Limbergen, E.
    Neven, P.
    Punie, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [35] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Haeyoung Kim
    Dae-Yeon Cho
    Doo Ho Choi
    Mijin Oh
    Inkyung Shin
    Won Park
    Seung Jae Huh
    Seok Jin Nam
    Jeong Eon Lee
    Seok Won Kim
    Breast Cancer Research and Treatment, 2017, 161 : 95 - 102
  • [36] Clinicopathologic and Genetic Characteristics of Breast Cancers in Patients with CHEK2 Alterations
    Schwartz, Christopher
    Khorsandi, Nikka
    Blanco, Amie
    Mukhtar, Rita
    Chen, Yunn-Yi
    Krings, Gregor
    LABORATORY INVESTIGATION, 2023, 103 (03) : S208 - S209
  • [37] Germline PALB2 heterozygous mutations in breast cancers: Haploinsufficiency paradigm
    Ouyang, Q.
    Hu, Z-Y.
    Liu, L.
    Gao, J.
    Wu, H.
    Lu, J.
    Xie, N.
    Tian, C.
    Liu, Z.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] A PALB2 mutation associated with high risk of breast cancer
    Southey, Melissa C.
    Teo, Zhi L.
    Dowty, James G.
    Odefrey, Fabrice A.
    Park, Daniel J.
    Tischkowitz, Marc
    Sabbaghian, Nelly
    Apicella, Carmel
    Byrnes, Graham B.
    Winship, Ingrid
    Baglietto, Laura
    Giles, Graham G.
    Goldgar, David E.
    Foulkes, William D.
    Hopper, John L.
    BREAST CANCER RESEARCH, 2010, 12 (06)
  • [39] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Kim, Haeyoung
    Cho, Dae-Yeon
    Choi, Doo Ho
    Oh, Mijin
    Shin, Inkyung
    Park, Won
    Huh, Seung Jae
    Nam, Seok Jin
    Lee, Jeong Eon
    Kim, Seok Won
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 95 - 102
  • [40] A PALB2 mutation associated with high risk of breast cancer
    Melissa C Southey
    Zhi L Teo
    James G Dowty
    Fabrice A Odefrey
    Daniel J Park
    Marc Tischkowitz
    Nelly Sabbaghian
    Carmel Apicella
    Graham B Byrnes
    Ingrid Winship
    Laura Baglietto
    Graham G Giles
    David E Goldgar
    William D Foulkes
    John L Hopper
    Breast Cancer Research, 12
12345